Komatsu Hiroaki, Furukawa Nao, Kinoshita Hirotaka, Aratame Atsutaka, Baba Toshio, Okabe Kazunori
Department of Thoracic Surgery, Bell-Land General Hospital, 500-3, Higashiyama, Naka-ku, Sakai-shi, Osaka, 599-8247, Japan.
Department of Cardiovascular Surgery, Bell-Land General Hospital, 500-3, Higashiyama, Naka-ku, Sakai-shi, Osaka, 599-8247, Japan.
Surg Case Rep. 2024 Mar 8;10(1):55. doi: 10.1186/s40792-024-01855-4.
Combined resection of lung cancer and the thoracic aortic wall with thoracic aortic endografting has been reported. However, whether the resection and endografting should be performed simultaneously or in two steps remains controversial.
A 68-year-old man was referred to our hospital because of left chest pain. Chest contrast-enhanced computed tomography revealed a huge tumor of the left lower lung lobe, and invasion to the aortic wall was suspected. Bronchoscopic examination was performed, revealing squamous cell carcinoma with a programmed death ligand 1 expression level of 90%. The clinical stage was T4N0M0 stage 3A. After neoadjuvant chemotherapy and radiotherapy, we performed one-stage surgery with the patient in the right lateral decubitus position and the left inguinal region exposed for femoral vessel isolation. Posterolateral thoracotomy was performed with making a latissimus dorsi muscle flap. The pulmonary artery, vein, and left lower bronchus were cut with a stapler. After hilar isolation, we evaluated the involvement of the descending aorta and marked the area of the involved aortic wall by a surgical clip. Using the left femoral artery approach, a GORE TAG conformable thoracic stent graft was delivered to the descending aorta. After thoracic aortic endografting, the involved aortic wall was resected and the left lower lobe of the lung and resected aortic wall were resected en bloc. The adventitial defect was covered by the latissimus dorsi muscle flap. The operating time was 474 min, and the blood loss volume was 330 mL. The postoperative pathological diagnosis was adenocarcinoma with an epidermal growth factor receptor mutation of exon 19 deletion. The residual viable tumor was 7 mm in diameter and close to the resected aortic wall. The patient's postoperative course was uneventful. Five days after surgery, chest contrast-enhanced computed tomography revealed no endoleak or stent migration. Three months after surgery, he was alive with neither recurrence nor stent graft-related complications.
One-stage surgery involving combined resection of lung cancer and the thoracic aortic wall with simultaneous thoracic aortic endografting in the right lateral decubitus position with the left inguinal region exposed is safe and acceptable.
已有报道肺癌合并胸主动脉壁切除并进行胸主动脉腔内修复术。然而,切除和腔内修复术应同期进行还是分两步进行仍存在争议。
一名68岁男性因左胸痛转诊至我院。胸部增强计算机断层扫描显示左肺下叶有巨大肿瘤,怀疑侵犯主动脉壁。进行了支气管镜检查,显示为鳞状细胞癌,程序性死亡配体1表达水平为90%。临床分期为T4N0M0 3A期。新辅助化疗和放疗后,我们让患者取右侧卧位,暴露左腹股沟区以便分离股血管,进行一期手术。采用背阔肌肌瓣行后外侧开胸术。用吻合器切断肺动脉、肺静脉和左肺下叶支气管。肺门游离后,评估降主动脉受累情况,并用手术夹标记受累主动脉壁区域。通过左股动脉途径,将GORE TAG顺应性胸主动脉覆膜支架输送至降主动脉。胸主动脉腔内修复术后,切除受累主动脉壁,将左肺下叶和切除的主动脉壁整块切除。外膜缺损用背阔肌肌瓣覆盖。手术时间为474分钟,失血量为330毫升。术后病理诊断为腺癌,表皮生长因子受体第19外显子缺失突变。残留存活肿瘤直径为7毫米,靠近切除的主动脉壁。患者术后恢复顺利。术后5天,胸部增强计算机断层扫描显示无内漏或支架移位。术后3个月,患者存活,无复发及支架相关并发症。
在暴露左腹股沟区的右侧卧位下同期进行肺癌合并胸主动脉壁切除及胸主动脉腔内修复术的一期手术是安全且可接受的。